You are here

Novoron Bioscience Inc.

Company Information
Address 7770 Regents Rd 113 319
San Diego, CA, 92122-1937


Information

DUNS: 078781043

# of Employees: 3


Ownership Information

HUBZone Owned: N

Socially and Economically Disadvantaged: Y

Woman Owned: N



Award Charts




Award Listing

  1. NOVO-118 as a therapeutic to promote remyelination in in vivo models of MS

    Amount: $353,084.00

    Project Summary Multiple sclerosisMSis a neurodegenerative disease in which myelin of the central nervous systemCNSis destroyed by a self reactive immune responseThis demyelination is accompanied by t ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  2. Assessment of NOVO-118 as a regenerative therapeutic in acute spinal cord injury

    Amount: $695,052.00

    Project Summary The purpose of this proposal is to conduct a rigorous in vivo efficacy study to test the activity of our optimized lead moleculeNOVOin an animal model of spinal cord injurySCISCI preva ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  3. RAP as a novel therapeutic to promote remyelination after MS demyelinating event

    Amount: $673,853.00

    DESCRIPTION provided by applicant Multiple sclerosis MS is a chronic and largely unpredictable disease of the central nervous system CNS characterized by autoimmune activity against the myelin ...

    SBIRPhase I2015Department of Health and Human Services
  4. RAP as a therapeutic for regeneration of the optic nerve after insult

    Amount: $264,553.00

    DESCRIPTION provided by applicant Like all neurons of the central nervous system CNS retinal ganglion cells fail to regenerate and often die after damage to the optic nerve such as occurs in o ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
  5. RAP as a therapeutic compound for neuronal regeneration after spinal cord injury

    Amount: $330,056.00

    DESCRIPTION provided by applicant RAP as a therapeutic compound for neuronal regeneration after spinal cord injury Novoron Bioscience Inc RESEARCH andamp RELATED Other Project Information Pro ...

    STTRPhase I2014Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government